{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:40:55Z","timestamp":1649101255498},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLINID"],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1093\/cid\/ciw713","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T19:05:23Z","timestamp":1477076723000},"page":"391-391","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Johnson"],"prefix":"10.1093","volume":"64","author":[{"given":"Florian M.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne B.","family":"Gasink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"2017011719001756000_64.3.391.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.009"},{"key":"2017011719001756000_64.3.391.2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(88)90053-3"},{"key":"2017011719001756000_64.3.391.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"2017011719001756000_64.3.391.4","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.Supplement_1.S216"},{"key":"2017011719001756000_64.3.391.5","unstructured":"Rubin UHSE Andriole VT Davis RJ Stamm WE; European Working Party (Norrby SR) . General guidelines for the evaluation of new anti-infective drugs for the treatment of UTI. Clin Microbiol Infect Dis 1993; 294\u2013310."},{"key":"2017011719001756000_64.3.391.6","unstructured":"Grabe M Bartoletti R Bjerklund Johansen TE . Guidelines on urological infections. Available at: http:\/\/uroweb.org\/wp-content\/uploads\/19-Urological-infections_LR2.pdf. Accessed 23 September 2016."},{"key":"2017011719001756000_64.3.391.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw378"},{"key":"2017011719001756000_64.3.391.8","unstructured":"US Food and Drug Administration. Guidance for industry on complicated urinary tract infections: developing drugs for treatment. Draft guidance. Available at: http:\/\/www.regulations.gov\/contentStreamer?documentId=FDA-2012-D-0148-0002&attachmentNumber=1&disposition=attachment&contentType=pdf. Accessed 23 September 2016."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/3\/391\/9544896\/ciw713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T02:55:17Z","timestamp":1503629717000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/ciw713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,1,17]]},"published-print":{"date-parts":[[2017,2,1]]}},"alternative-id":["10.1093\/cid\/ciw713"],"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw713","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}